lupus nephritis

Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Fierce Pharma
Catalent
Aurinia Pharmaceuticals
lupus nephritis
Lupkynis
CDMOs
Flag link:
Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing
Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing
Xtalks
FDA
Aurinia Pharmaceuticals
Lupkynis
voclosporin
lupus nephritis
Flag link:
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Fierce Pharma
Aurinia
FDA
Lupkynis
voclosporin
lupus nephritis
Flag link:
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
Flag link:
Aurinia announces FDA acceptance of NDA filing and priority review for voclosporin to treat lupus nephritis
Aurinia announces FDA acceptance of NDA filing and priority review for voclosporin to treat lupus nephritis
Pharmaceutical Business Review
Aurinia
voclosporin
FDA
lupus nephritis
Flag link:
Aurinia initiates rolling submission of a new drug application to the FDA for Voclosporin in the treatment of lupus nephritis
Aurinia initiates rolling submission of a new drug application to the FDA for Voclosporin in the treatment of lupus nephritis
Pharmaceutical Business Review
Aurinia Pharmaceuticals
FDA
voclosporin
lupus nephritis
Flag link:
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Stat
Aurinia Pharmaceuticals
lupus nephritis
clinical trials
voclosporin
autoimmune kidney disease
Flag link:
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Motley Fool
Aurinia Pharmaceuticals
clinical trials
voclosporin
lupus nephritis
Flag link:
After touting Gazyva's potential in lupus, Roche nabs 'breakthrough' ahead of PhIII
After touting Gazyva's potential in lupus, Roche nabs 'breakthrough' ahead of PhIII
Endpoints
Roche
Gazyva
lupus nephritis
Flag link:
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Fierce Pharma
Roche
FDA
lupus nephritis
Gazyva
Flag link:
New Data Suggests Aurinia Pharmaceuticals Is Onto Something Big
New Data Suggests Aurinia Pharmaceuticals Is Onto Something Big
Motley Fool
Aurinia Pharmaceuticals
voclosporin
CellCept
lupus nephritis
Flag link: